Back to Search
Start Over
Researchers Submit Patent Application, 'Par-4 Agonists For The Treatment Of Cancer', for Approval (USPTO 20200046721)
- Source :
- Cancer Gene Therapy Week. March 2, 2020, 145
- Publication Year :
- 2020
-
Abstract
- 2020 MAR 2 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors [...]
- Subjects :
- Cipla Ltd. -- Intellectual property
Cabazitaxel
Ixazomib
Ceritinib
Ionizing radiation
Cobimetinib
Ruxolitinib
Siltuximab
Alectinib
BCR-ABL tyrosine kinase inhibitors
Ramucirumab
Trifluridine
Olaparib
Nivolumab
Carboplatin
Obinutuzumab
Antibacterial agents
Cancer genetics -- Genetic aspects
Osimertinib
Cancer -- Genetic aspects
Monoclonal antibodies
Pembrolizumab
Belinostat
Decitabine
Palbociclib
Idelalisib
Blinatumomab
Bevacizumab
Pharmaceutical industry -- Intellectual property
Antineoplastic agents
Afatinib
Cancer treatment
Anopheles
Temsirolimus
Cabozantinib
Fulvestrant
Clofarabine
Pertuzumab
Dasatinib
Nelarabine
Ixabepilone
Axitinib
Vincristine
Ibrutinib
Editors
Sonidegib
Lenvatinib
Nilotinib
Tositumomab
Abiraterone
Dabrafenib
Pemetrexed
Vandetanib
Cetuximab
Carfilzomib
Romidepsin
Atezolizumab
Ipilimumab
Vismodegib
Trabectedin
Elotuzumab
Pralatrexate
Enzalutamide
Sunitinib
Regorafenib
Crizotinib
Necitumumab
Lapatinib
Degarelix
Public health
Dinutuximab
Everolimus
Vorinostat
Ponatinib
Bosutinib
Public health movements
Panitumumab
Brentuximab vedotin
Ofatumumab
Sorafenib
Bendamustine
Ibritumomab tiuxetan
Trametinib
Denosumab
Vemurafenib
Pazopanib
Panobinostat
Daratumumab
Biotechnology industry
Health
Science and technology
Subjects
Details
- Language :
- English
- ISSN :
- 15436829
- Database :
- Gale General OneFile
- Journal :
- Cancer Gene Therapy Week
- Publication Type :
- News
- Accession number :
- edsgcl.615830097